Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study

Kosuke Ebina; Motomu Hashimoto; Wataru Yamamoto; Tôru Hirano; Ryota Hara; Masaki Katayama; Akira Ōnishi; Koji Nagai; Yonsu Son; Hideki Amuro; Keiichi Yamamoto; Yuichi Maeda; Koichi Murata; Sadao Jinno; Tohru Takeuchi; Makoto Hirao; Atsushi Kumanogoh; Hideki Yoshikawa

doi:10.1186/s13075-019-1880-4

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

TCZ showed the lowest discontinuation rate by lack of effectiveness, ABT showed the lowest discontinuation rate by toxic adverse events, ADA and IFX showed the highest discontinuation rate by remission, and ABT showed the highest overall retention rates (excluding non-toxic reasons and remission) among seven bDMARDs in the adjusted model.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ebina et al. (2019) studied this question.

synapsesocial.com/papers/69d7f8e93b601d7be3ae37e7 https://doi.org/10.1186/s13075-019-1880-4

View Full Paper

Ask AI

Bookmark

Share

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study

Ask about this paper

Abstract

Discussion

Cite This Study

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading